Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Share Price
Equities
301126
CNE1000054V3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.48 CNY | +1.85% | +2.95% | -19.57% |
Sales 2022 | 3.29B 456M 36.19B | Sales 2023 | 3.9B 540M 42.91B | Capitalization | 2.69B 373M 29.58B |
---|---|---|---|---|---|
Net income 2022 | 51M 7.06M 561M | Net income 2023 | 34M 4.71M 374M | EV / Sales 2022 | 1.23 x |
Net Debt 2022 | 967M 134M 10.63B | Net Debt 2023 | 1.92B 266M 21.16B | EV / Sales 2023 | 1.18 x |
P/E ratio 2022 |
59.6
x | P/E ratio 2023 |
76.6
x | Employees | 3,461 |
Yield 2022 |
0.19% | Yield 2023 |
0.31% | Free-Float | 37.57% |
1 day | +1.85% | ||
1 week | +2.95% | ||
Current month | +9.85% | ||
1 month | +14.16% | ||
3 months | +38.81% | ||
6 months | -24.82% | ||
Current year | -19.57% |
Managers | Title | Age | Since |
---|---|---|---|
Sheng Li Hu
CEO | Chief Executive Officer | 50 | 15/04/17 |
Juan Tang
CHM | Chairman | 53 | 30/06/02 |
Yi Qing Wang
CHM | Chairman | 59 | 30/09/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhi Tang
BRD | Director/Board Member | 51 | 13/11/19 |
Shu Ping Liu
BRD | Director/Board Member | 54 | 09/09/20 |
Yi Qing Wang
CHM | Chairman | 59 | 30/09/02 |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 10.48 | +1.85% | 12,835,470 |
13/05/24 | 10.29 | -7.05% | 15,295,670 |
10/05/24 | 11.07 | -10.36% | 28,471,750 |
09/05/24 | 12.35 | +20.02% | 23,631,870 |
08/05/24 | 10.29 | +1.08% | 5,913,674 |
End-of-day quote Shenzhen S.E., May 13, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-19.57% | 299M | |
+19.14% | 71.7B | |
-3.34% | 23.73B | |
+10.27% | 9.01B | |
+12.67% | 8.72B | |
-17.41% | 8.29B | |
+9.65% | 5B | |
+21.40% | 4.48B | |
-1.41% | 4.08B | |
-1.99% | 3.92B |
- Stock Market
- Equities
- 301126 Stock